-Reuters
ZyVersa Therapeutics Announces A Publication In Frontiers In Medicine Showing Direct Inflammasome Activation In Children With Juvenile Idiopathic Arthritis
Juvenile idiopathic arthritis ("JIA"), a complex autoimmune inflammatory disorder, is the most common childhood chronic rheumatic disease
This is the first report documenting inflammasome activation in the